Congenital vitamin K deficiency or altered coagulation resulting from maternal phenobarbital exposure can be effectively prevented or corrected using standard vitamin K administration.
The retrieved literature supports the premise that vitamin K administration serves as an effective preventive and corrective measure against bleeding risks associated with maternal anticonvulsant drugs such as phenobarbital.